 | • レポートコード：MRC2-11QY04203 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はペプチド癌治療薬のグローバル市場について調査・分析したレポートです。種類別（ゴセレリン、ボルテゾミブ、リュープロレリン、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ペプチド癌治療薬の競争状況、市場シェア ・世界のペプチド癌治療薬市場：種類別市場規模 2015年-2020年（ゴセレリン、ボルテゾミブ、リュープロレリン、その他） ・世界のペプチド癌治療薬市場：種類別市場規模予測 2021年-2026年（ゴセレリン、ボルテゾミブ、リュープロレリン、その他） ・世界のペプチド癌治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界のペプチド癌治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米のペプチド癌治療薬市場分析：米国、カナダ ・ヨーロッパのペプチド癌治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのペプチド癌治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のペプチド癌治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのペプチド癌治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、AstraZeneca、Johnson & Johnson、Abbott Laboratories、Allergan、AbbVie、Bausch Health、Takeda Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer.
Market Analysis and Insights: Global Peptide Based Cancer Therapeutics Market
The global Peptide Based Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Peptide Based Cancer Therapeutics Scope and Market Size
Peptide Based Cancer Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Based Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
AstraZeneca
Johnson & Johnson
Abbott Laboratories
Allergan
AbbVie
Bausch Health
Takeda Pharmaceutical
Market segment by Type, the product can be split into
Goserelin
Bortezomib
leuprorelin
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Peptide Based Cancer Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Peptide Based Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Goserelin
1.4.3 Bortezomib
1.4.4 leuprorelin
1.4.5 Others
1.5 Market by Application
1.5.1 Global Peptide Based Cancer Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Peptide Based Cancer Therapeutics Market Perspective (2015-2026)
2.2 Global Peptide Based Cancer Therapeutics Growth Trends by Regions
2.2.1 Peptide Based Cancer Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Peptide Based Cancer Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Peptide Based Cancer Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Peptide Based Cancer Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Peptide Based Cancer Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Peptide Based Cancer Therapeutics Players by Market Size
3.1.1 Global Top Peptide Based Cancer Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Peptide Based Cancer Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Peptide Based Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Peptide Based Cancer Therapeutics Market Concentration Ratio
3.2.1 Global Peptide Based Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Peptide Based Cancer Therapeutics Revenue in 2019
3.3 Peptide Based Cancer Therapeutics Key Players Head office and Area Served
3.4 Key Players Peptide Based Cancer Therapeutics Product Solution and Service
3.5 Date of Enter into Peptide Based Cancer Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Peptide Based Cancer Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Peptide Based Cancer Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Peptide Based Cancer Therapeutics Market Size by Application (2015-2020)
5.2 Global Peptide Based Cancer Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Peptide Based Cancer Therapeutics Market Size (2015-2020)
6.2 Peptide Based Cancer Therapeutics Key Players in North America (2019-2020)
6.3 North America Peptide Based Cancer Therapeutics Market Size by Type (2015-2020)
6.4 North America Peptide Based Cancer Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Peptide Based Cancer Therapeutics Market Size (2015-2020)
7.2 Peptide Based Cancer Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Peptide Based Cancer Therapeutics Market Size by Type (2015-2020)
7.4 Europe Peptide Based Cancer Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Peptide Based Cancer Therapeutics Market Size (2015-2020)
8.2 Peptide Based Cancer Therapeutics Key Players in China (2019-2020)
8.3 China Peptide Based Cancer Therapeutics Market Size by Type (2015-2020)
8.4 China Peptide Based Cancer Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Peptide Based Cancer Therapeutics Market Size (2015-2020)
9.2 Peptide Based Cancer Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Peptide Based Cancer Therapeutics Market Size by Type (2015-2020)
9.4 Japan Peptide Based Cancer Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Peptide Based Cancer Therapeutics Market Size (2015-2020)
10.2 Peptide Based Cancer Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Peptide Based Cancer Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Peptide Based Cancer Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Peptide Based Cancer Therapeutics Market Size (2015-2020)
11.2 Peptide Based Cancer Therapeutics Key Players in India (2019-2020)
11.3 India Peptide Based Cancer Therapeutics Market Size by Type (2015-2020)
11.4 India Peptide Based Cancer Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Peptide Based Cancer Therapeutics Market Size (2015-2020)
12.2 Peptide Based Cancer Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Peptide Based Cancer Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Peptide Based Cancer Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Peptide Based Cancer Therapeutics Introduction
13.1.4 Pfizer Revenue in Peptide Based Cancer Therapeutics Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview
13.2.3 AstraZeneca Peptide Based Cancer Therapeutics Introduction
13.2.4 AstraZeneca Revenue in Peptide Based Cancer Therapeutics Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Peptide Based Cancer Therapeutics Introduction
13.3.4 Johnson & Johnson Revenue in Peptide Based Cancer Therapeutics Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Details
13.4.2 Abbott Laboratories Business Overview
13.4.3 Abbott Laboratories Peptide Based Cancer Therapeutics Introduction
13.4.4 Abbott Laboratories Revenue in Peptide Based Cancer Therapeutics Business (2015-2020)
13.4.5 Abbott Laboratories Recent Development
13.5 Allergan
13.5.1 Allergan Company Details
13.5.2 Allergan Business Overview
13.5.3 Allergan Peptide Based Cancer Therapeutics Introduction
13.5.4 Allergan Revenue in Peptide Based Cancer Therapeutics Business (2015-2020)
13.5.5 Allergan Recent Development
13.6 AbbVie
13.6.1 AbbVie Company Details
13.6.2 AbbVie Business Overview
13.6.3 AbbVie Peptide Based Cancer Therapeutics Introduction
13.6.4 AbbVie Revenue in Peptide Based Cancer Therapeutics Business (2015-2020)
13.6.5 AbbVie Recent Development
13.7 Bausch Health
13.7.1 Bausch Health Company Details
13.7.2 Bausch Health Business Overview
13.7.3 Bausch Health Peptide Based Cancer Therapeutics Introduction
13.7.4 Bausch Health Revenue in Peptide Based Cancer Therapeutics Business (2015-2020)
13.7.5 Bausch Health Recent Development
13.8 Takeda Pharmaceutical
13.8.1 Takeda Pharmaceutical Company Details
13.8.2 Takeda Pharmaceutical Business Overview
13.8.3 Takeda Pharmaceutical Peptide Based Cancer Therapeutics Introduction
13.8.4 Takeda Pharmaceutical Revenue in Peptide Based Cancer Therapeutics Business (2015-2020)
13.8.5 Takeda Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Peptide Based Cancer Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Peptide Based Cancer Therapeutics Revenue
Table 3. Ranking of Global Top Peptide Based Cancer Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Peptide Based Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Goserelin
Table 6. Key Players of Bortezomib
Table 7. Key Players of leuprorelin
Table 8. Key Players of Others
Table 9. Global Peptide Based Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Peptide Based Cancer Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Peptide Based Cancer Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Peptide Based Cancer Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Peptide Based Cancer Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Peptide Based Cancer Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Peptide Based Cancer Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Peptide Based Cancer Therapeutics Players
Table 20. Global Peptide Based Cancer Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Peptide Based Cancer Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Peptide Based Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Based Cancer Therapeutics as of 2019)
Table 23. Global Peptide Based Cancer Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Peptide Based Cancer Therapeutics Product Solution and Service
Table 26. Date of Enter into Peptide Based Cancer Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Peptide Based Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Peptide Based Cancer Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Peptide Based Cancer Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Peptide Based Cancer Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Peptide Based Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Peptide Based Cancer Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Peptide Based Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Peptide Based Cancer Therapeutics Market Share (2019-2020)
Table 36. North America Peptide Based Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Peptide Based Cancer Therapeutics Market Share by Type (2015-2020)
Table 38. North America Peptide Based Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Peptide Based Cancer Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Peptide Based Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Peptide Based Cancer Therapeutics Market Share (2019-2020)
Table 42. Europe Peptide Based Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Peptide Based Cancer Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Peptide Based Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Peptide Based Cancer Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Peptide Based Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Peptide Based Cancer Therapeutics Market Share (2019-2020)
Table 48. China Peptide Based Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Peptide Based Cancer Therapeutics Market Share by Type (2015-2020)
Table 50. China Peptide Based Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Peptide Based Cancer Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Peptide Based Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Peptide Based Cancer Therapeutics Market Share (2019-2020)
Table 54. Japan Peptide Based Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Peptide Based Cancer Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Peptide Based Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Peptide Based Cancer Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Peptide Based Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Peptide Based Cancer Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Peptide Based Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Peptide Based Cancer Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Peptide Based Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Peptide Based Cancer Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Peptide Based Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Peptide Based Cancer Therapeutics Market Share (2019-2020)
Table 66. India Peptide Based Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Peptide Based Cancer Therapeutics Market Share by Type (2015-2020)
Table 68. India Peptide Based Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Peptide Based Cancer Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Peptide Based Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Peptide Based Cancer Therapeutics Market Share (2019-2020)
Table 72. Central & South America Peptide Based Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Peptide Based Cancer Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Peptide Based Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Peptide Based Cancer Therapeutics Market Share by Application (2015-2020)
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Product
Table 79. Pfizer Revenue in Peptide Based Cancer Therapeutics Business (2015-2020) (Million US$)
Table 80. Pfizer Recent Development
Table 81. AstraZeneca Company Details
Table 82. AstraZeneca Business Overview
Table 83. AstraZeneca Product
Table 84. AstraZeneca Revenue in Peptide Based Cancer Therapeutics Business (2015-2020) (Million US$)
Table 85. AstraZeneca Recent Development
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Product
Table 89. Johnson & Johnson Revenue in Peptide Based Cancer Therapeutics Business (2015-2020) (Million US$)
Table 90. Johnson & Johnson Recent Development
Table 91. Abbott Laboratories Company Details
Table 92. Abbott Laboratories Business Overview
Table 93. Abbott Laboratories Product
Table 94. Abbott Laboratories Revenue in Peptide Based Cancer Therapeutics Business (2015-2020) (Million US$)
Table 95. Abbott Laboratories Recent Development
Table 96. Allergan Company Details
Table 97. Allergan Business Overview
Table 98. Allergan Product
Table 99. Allergan Revenue in Peptide Based Cancer Therapeutics Business (2015-2020) (Million US$)
Table 100. Allergan Recent Development
Table 101. AbbVie Company Details
Table 102. AbbVie Business Overview
Table 103. AbbVie Product
Table 104. AbbVie Revenue in Peptide Based Cancer Therapeutics Business (2015-2020) (Million US$)
Table 105. AbbVie Recent Development
Table 106. Bausch Health Company Details
Table 107. Bausch Health Business Overview
Table 108. Bausch Health Product
Table 109. Bausch Health Revenue in Peptide Based Cancer Therapeutics Business (2015-2020) (Million US$)
Table 110. Bausch Health Recent Development
Table 111. Takeda Pharmaceutical Business Overview
Table 112. Takeda Pharmaceutical Product
Table 113. Takeda Pharmaceutical Company Details
Table 114. Takeda Pharmaceutical Revenue in Peptide Based Cancer Therapeutics Business (2015-2020) (Million US$)
Table 115. Takeda Pharmaceutical Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Based Cancer Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Goserelin Features
Figure 3. Bortezomib Features
Figure 4. leuprorelin Features
Figure 5. Others Features
Figure 6. Global Peptide Based Cancer Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Peptide Based Cancer Therapeutics Report Years Considered
Figure 11. Global Peptide Based Cancer Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Peptide Based Cancer Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Peptide Based Cancer Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Peptide Based Cancer Therapeutics Market Share by Players in 2019
Figure 16. Global Top Peptide Based Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Based Cancer Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Peptide Based Cancer Therapeutics Revenue in 2019
Figure 18. North America Peptide Based Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Peptide Based Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Peptide Based Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Peptide Based Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Peptide Based Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Peptide Based Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Peptide Based Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
ペプチド胃腸障害治療薬の世界市場（～2026年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…- ペプチド感染症治療薬の世界市場（～2026年） Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. Market Analysis and Insights: Global Peptide Based Infection Therapeutics Market The global Peptide …
- ペプチド心血管治療薬の世界市場（～2026年） Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart diseas…
- ペプチド代謝障害治療薬の世界市場（～2026年） A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive. Peptide therapeutics are used to treat metabolic disorders owing to their stability, effici…
- 肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ 15800 million by 2026, from US$ 14180 million in 2020, at a CAGR of 10.6%% during 2021-2026. Global Lung Cancer Therapeutics Scope and Market Size Lung Cance…